AI model predicts which animal viruses are likely to jump to humans
Identifying diseases before they become a threat to humans is challenging, because only a few of the nearly 2 million animal viruses can infect humans. By developing machine learning models, researchers can analyze genetic patterns of viruses that might infect people.
“Our findings show that the zoonotic potential of viruses can be inferred to a surprisingly large extent from their genome sequence,” the researchers at the University of Glasgow reported. “By highlighting viruses with the greatest potential to become zoonotic, genome-based ranking allows further ecological and virological characterization to be targeted more effectively.”
The researchers said the models are only a first step in identifying animal viruses with the potential to infect humans, however. Viruses flagged by the models will need laboratory test confirmation before researchers pursue funding for further study.
Although these models may predict if viruses might infect humans, that’s only one part of the broader risk. Zoonotic risk is also influenced by how destructive a virus is in humans, as well as its ability to transmit between people, and ecological conditions at the time of human exposure.
The findings were published online Sept. 28 in the journal PLoS Biology.
Co-author Simon Babayan of the Institute of Biodiversity at the University of Glasgow said these findings add important information to that gleaned from genetic sequencing of viruses using AI techniques.
“A genomic sequence is typically the first, and often only, information we have on newly discovered viruses, and the more information we can extract from it, the sooner we might identify the virus’ origins and the zoonotic risk it may pose,” he said in a journal news release.
“As more viruses are characterized, the more effective our machine learning models will become at identifying the rare viruses that ought to be closely monitored and prioritized for preemptive vaccine development,” Babayan added.
04 Jan 2023gMendel® wins €500k grant from the EUROSTARS funding programme to develop a novel non-invasive prenatal screening tool for detection of genetic disorders powered by AI.
22 Dec 2022The Year in Review. As 2022 draws to a close, explore gMendel’s round-up of activities that dominated the year.
15 Nov 2022gMendel® announced today its first Board of Directors and appointments of Lars Staal Wegner, Chairman, and Hanna Pyokari, Member, effective November 1st, 2022.
27 Sep 2022gMendel® moves into an investment agreement with Polish biotech company genXone for further cooperation in diagnosis of genetic disorders.